Clinicopathological and prognostic implications of EGFR mutations subtypes in Moroccan non-small cell lung cancer patients: A first report.

doi:10.1371/journal.pone.0298721

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinicopathological and prognostic implications of EGFR mutations subtypes in Moroccan non-small cell lung cancer patients: A first report.

PloS one - 1 Jan 2024

Boukansa Sara, Mouhrach Ismail, El Agy Fatima, El Bardai Sanae, Bouguenouch Laila, Serraj Mounia, Amara Bouchra, Ouadnouni Yassine, Smahi Mohamed, Alami Badreeddine, Mellas Nawfel, Benbrahim Zineb, El Fatemi Hinde

Abstract excerpt

BACKGROUND: Non-small cell lung cancer (NSCLC) remains a significant global health concern, with EGFR mutations playing a pivotal role in guiding treatment decisions. This prospective study investigated the prevalence and clinical implications of EGFR mutations in Moroccan NSCLC patients. METHODS: A cohort of 302 NSCLC patients was analyzed for EGFR mutations using multiple techniques. Demographic, clinical, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Morocco

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 38837980
DOI: 10.1371/journal.pone.0298721
PMCID: PMC11152259

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships.